​
​

Immunocore (IMCR) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Immunocore Revenue Highlights

Latest Revenue (Y)

$249.43M

Latest Revenue (Q)

$75.40M

Main Segment (Y)

Product Revenue

Main Geography (Y)

UNITED STATES

Immunocore Revenue by Period

Immunocore Revenue by Year

DateRevenueChange
2023-12-31-73.53%
2022-12-31-441.99%
2021-12-31--11.93%
2020-12-31-17.32%
2019-12-31-8.52%
2018-12-31--

Immunocore generated $249.43M in revenue during NA 2023, up 73.53% compared to the previous quarter, and up 1054.49% compared to the same period a year ago.

Immunocore Revenue by Quarter

DateRevenueChange
2024-06-30-6.95%
2024-03-31--33.26%
2023-12-31-68.68%
2023-09-30-3.54%
2023-06-30-9.86%
2023-03-31-14.55%
2022-12-31-16.66%
2022-09-30-28.74%
2022-06-30-42.40%
2022-03-31-240.88%
2021-12-31-11.29%
2021-09-30-3.33%
2021-06-30--30.68%
2021-03-31-11.46%
2020-12-31-11.55%
2020-09-30--14.58%
2020-06-30--5.67%
2020-03-31-46.31%
2019-12-31--

Immunocore generated $75.40M in revenue during Q2 2024, up 6.95% compared to the previous quarter, and up 136.95% compared to the same period a year ago.

Immunocore Revenue Breakdown

Immunocore Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20
Product Revenue----
Genentech----
GlaxoSmithKline----
Eli Lilly----
Med Immune----

Immunocore's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product Revenue (100.00%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24
Product--
Product Revenue--
Collaboration Revenue--

Immunocore's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (100.00%).

Immunocore Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20
Rest of World----
UNITED STATES----
Europe----
United States----
UK----

Immunocore's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (70.45%), Europe (28.06%), and Rest of World (1.49%).

Quarterly Revenue by Country

CountrySep 24Mar 24
Europe--
International--
UNITED STATES--
Rest of World--

Immunocore's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (71.36%), Europe (26.29%), and International (2.35%).

Immunocore Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
IMCRImmunocore--
MIRMMirum Pharmaceuticals--
ACLXArcellx--
LYRALyra Therapeutics--
VRDNViridian Therapeutics--
DSGNDesign Therapeutics--
GRCLGracell Bio--
PCVXVaxcyte--
NUVLNuvalent--
DICEDICE Therapeutics--
ERASErasca--
VTYXVentyx Biosciences--
LRMRLarimar Therapeutics--
GLUEMonte Rosa Therapeutics--
KALVKalVista Pharmaceuticals--

IMCR Revenue FAQ

What is Immunocore’s yearly revenue?

Immunocore's yearly revenue for 2023 was $249.43M, representing an increase of 73.53% compared to 2022. The company's yearly revenue for 2022 was $143.74M, representing an increase of 441.99% compared to 2021. IMCR's yearly revenue for 2021 was $26.52M, representing a decrease of -11.93% compared to 2020.

What is Immunocore’s quarterly revenue?

Immunocore's quarterly revenue for Q2 2024 was $75.4M, a 6.95% increase from the previous quarter (Q1 2024), and a 24.66% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $70.5M, a -33.26% decrease from the previous quarter (Q4 2023), and a 28.06% increase year-over-year (Q1 2023). IMCR's quarterly revenue for Q4 2023 was $105.64M, a 68.68% increase from the previous quarter (Q3 2023), and a 119.79% increase year-over-year (Q4 2022).

What is Immunocore’s revenue growth rate?

Immunocore's revenue growth rate for the last 3 years (2021-2023) was 840.53%, and for the last 5 years (2019-2023) was 871.71%.

What are Immunocore’s revenue streams?

Immunocore's revenue streams in c 23 are Product Revenue

What is Immunocore’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Immunocore was Product Revenue. This segment made a revenue of $238.74M, representing 100.00% of the company's total revenue.